Liu J - Search Results

1

miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma.

Liu J, Yan J, Zhou C, Ma Q, Jin Q, Yang Z. Liu J, et al. Tumour Biol. 2015 Jan;36(1):219-25. doi: 10.1007/s13277-014-2622-5. Epub 2014 Sep 18. Tumour Biol. 2015. PMID: 25230788

2

microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma.

Zhou C, Liu J, Li Y, Liu L, Zhang X, Ma CY, Hua SC, Yang M, Yuan Q. Zhou C, et al. Among authors: liu j, liu l. FEBS Lett. 2011 Jun 23;585(12):1828-34. doi: 10.1016/j.febslet.2011.04.040. Epub 2011 Apr 23. FEBS Lett. 2011. PMID: 21530512 Free article.

3

Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.

Tan X, Xie P, Liu J, Wu H, Xie Y. Tan X, et al. Among authors: liu j. Asia Pac J Clin Oncol. 2015 Sep;11(3):e6-e12. doi: 10.1111/ajco.12272. Epub 2014 Sep 16. Asia Pac J Clin Oncol. 2015. PMID: 25228074

4

Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.

Liu M, Liu J, Wang L, Wu H, Zhou C, Zhu H, Xu N, Xie Y. Liu M, et al. Among authors: liu j. PLoS One. 2014 Oct 2;9(10):e109347. doi: 10.1371/journal.pone.0109347. eCollection 2014. PLoS One. 2014. PMID: 25275448 Free PMC article.

5

The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8.

Pan W, Zhang N, Liu W, Liu J, Zhou L, Liu Y, Yang M. Pan W, et al. Among authors: liu j, liu y, liu w. J Biol Chem. 2018 Nov 2;293(44):17154-17165. doi: 10.1074/jbc.RA118.003055. Epub 2018 Sep 18. J Biol Chem. 2018. PMID: 30228180 Free PMC article.

6

The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.

Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, Xie M, Lei T, Zhang N, Yang M. Wei L, et al. Among authors: liu j. Mol Cancer. 2019 Oct 25;18(1):147. doi: 10.1186/s12943-019-1086-z. Mol Cancer. 2019. PMID: 31651347 Free PMC article. Review.

7

Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis.

Xiong X, Yuan J, Zhang N, Zheng Y, Liu J, Yang M. Xiong X, et al. Among authors: liu j. Biochem Biophys Res Commun. 2020 Jan 8;521(2):478-484. doi: 10.1016/j.bbrc.2019.10.137. Epub 2019 Oct 31. Biochem Biophys Res Commun. 2020. PMID: 31677796

8

N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.

Liu J, Wang D, Zhou J, Wang L, Zhang N, Zhou L, Zeng J, Liu J, Yang M. Liu J, et al. Arch Toxicol. 2021 May;95(5):1621-1629. doi: 10.1007/s00204-021-03021-3. Epub 2021 Mar 13. Arch Toxicol. 2021. PMID: 33713148

9

Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization.

Wu ZJ, Xie YF, Chang X, Zhang L, Wu HY, Liu JB, Zhang JX, Sun P. Wu ZJ, et al. Med Sci Monit. 2021 May 10;27:e929884. doi: 10.12659/MSM.929884. Med Sci Monit. 2021. PMID: 33967266 Free PMC article.

10

Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism.

Liu J, Wu Z, Zhang J, Xie Y, Sun P, Wu H, Chang X, Zhang L, Liu F. Liu J, et al. Among authors: liu f. Medicine (Baltimore). 2021 Jul 2;100(26):e26441. doi: 10.1097/MD.0000000000026441. Medicine (Baltimore). 2021. PMID: 34190168 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,141 results

Search Page

Filters